Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Kineta Inc. is raising $5,000,000.00 in a new round of investment. Sources indicate as part of senior management President, Craig Philips played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Kineta Inc.

Kineta, Inc. is a clinical stage biotechnology company committed to developing disruptive life science technologies that address unmet patient needs. We have leveraged our expertise in immunology to advance a focused pipeline of investigational drugs in oncology, neuroscience and virology. We actively collaborate with a broad array of private, government and industry partners to advance our innovative research. Kineta has established strategic partnerships with leading science-driven organizations to accelerate the development of our pipeline of novel immunotherapies. To learn more about Kineta Inc., visit http://www.kinetabio.com/

Contact:
Craig Philips, President
206-378-0400
cphilips@kinetabio.com
https://www.linkedin.com/in/craigphilips/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved